These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
|
|
For the quarterly period ended March 31, 2016
|
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
|
|
For the transition period from to
|
|
CAYMAN ISLANDS
|
N/A
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. employer identification no.)
|
|
65 MARKET STREET
SUITE 1207, CAMANA BAY
P.O. BOX 31110
GRAND CAYMAN
CAYMAN ISLANDS
|
KY1-1205
|
|
(Address of principal executive offices)
|
(Zip code)
|
|
Class A Ordinary Shares, $0.10 par value
|
30,977,642
|
|
Class B Ordinary Shares, $0.10 par value
|
6,254,895
|
|
(Class)
|
Outstanding as of April 29, 2016
|
|
|
|
Page
|
|
|
Condensed Consolidated Balance Sheets as of March 31, 2016 (unaudited) and December 31, 2015
|
|
|
|
Condensed Consolidated Statements of Income for the three months ended March 31, 2016 and 2015 (unaudited)
|
|
|
|
Condensed Consolidated Statements of Shareholders' Equity for the three months ended March 31, 2016 and 2015 (unaudited)
|
|
|
|
Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2016 and 2015 (unaudited)
|
|
|
|
Notes to the Condensed Consolidated Financial Statements (unaudited)
|
|
|
|
March 31, 2016
|
|
December 31, 2015
|
||||
|
|
(unaudited)
|
|
(audited)
|
||||
|
Assets
|
|
|
|
||||
|
Investments
|
|
|
|
||||
|
Debt instruments, trading, at fair value
|
$
|
73,879
|
|
|
$
|
39,087
|
|
|
Equity securities, trading, at fair value
|
934,232
|
|
|
905,994
|
|
||
|
Other investments, at fair value
|
190,516
|
|
|
119,083
|
|
||
|
Total investments
|
1,198,627
|
|
|
1,064,164
|
|
||
|
Cash and cash equivalents
|
196,134
|
|
|
112,162
|
|
||
|
Restricted cash and cash equivalents
|
1,157,656
|
|
|
1,236,589
|
|
||
|
Financial contracts receivable, at fair value
|
13,286
|
|
|
13,215
|
|
||
|
Reinsurance balances receivable
|
246,862
|
|
|
187,940
|
|
||
|
Loss and loss adjustment expenses recoverable
|
3,548
|
|
|
3,368
|
|
||
|
Deferred acquisition costs, net
|
68,184
|
|
|
59,823
|
|
||
|
Unearned premiums ceded
|
2,805
|
|
|
3,251
|
|
||
|
Notes receivable
|
35,537
|
|
|
25,146
|
|
||
|
Other assets
|
7,189
|
|
|
6,864
|
|
||
|
Total assets
|
$
|
2,929,828
|
|
|
$
|
2,712,522
|
|
|
Liabilities and equity
|
|
|
|
||||
|
Liabilities
|
|
|
|
||||
|
Securities sold, not yet purchased, at fair value
|
$
|
876,248
|
|
|
$
|
882,906
|
|
|
Financial contracts payable, at fair value
|
9,106
|
|
|
28,245
|
|
||
|
Due to prime brokers
|
544,481
|
|
|
396,453
|
|
||
|
Loss and loss adjustment expense reserves
|
341,132
|
|
|
305,997
|
|
||
|
Unearned premium reserves
|
237,919
|
|
|
211,954
|
|
||
|
Reinsurance balances payable
|
19,704
|
|
|
18,326
|
|
||
|
Funds withheld
|
7,036
|
|
|
7,143
|
|
||
|
Other liabilities
|
12,146
|
|
|
12,725
|
|
||
|
Performance compensation payable to related party
|
3,081
|
|
|
—
|
|
||
|
Total liabilities
|
2,050,853
|
|
|
1,863,749
|
|
||
|
Equity
|
|
|
|
||||
|
Preferred share capital (par value $0.10; authorized, 50,000,000; none issued)
|
—
|
|
|
—
|
|
||
|
Ordinary share capital (Class A: par value $0.10; authorized, 100,000,000; issued and outstanding, 30,977,642 (2015: 30,772,572): Class B: par value $0.10; authorized, 25,000,000; issued and outstanding, 6,254,895 (2015: 6,254,895))
|
3,723
|
|
|
3,703
|
|
||
|
Additional paid-in capital
|
497,141
|
|
|
496,401
|
|
||
|
Retained earnings
|
353,956
|
|
|
325,287
|
|
||
|
Shareholders’ equity attributable to shareholders
|
854,820
|
|
|
825,391
|
|
||
|
Non-controlling interest in joint venture
|
24,155
|
|
|
23,382
|
|
||
|
Total equity
|
878,975
|
|
|
848,773
|
|
||
|
Total liabilities and equity
|
$
|
2,929,828
|
|
|
$
|
2,712,522
|
|
|
|
|
Three months ended March 31
|
||||||
|
|
|
2016
|
|
2015
|
||||
|
Revenues
|
|
|
|
|
||||
|
Gross premiums written
|
|
$
|
166,792
|
|
|
$
|
129,682
|
|
|
Gross premiums ceded
|
|
(2,107
|
)
|
|
(1,626
|
)
|
||
|
Net premiums written
|
|
164,685
|
|
|
128,056
|
|
||
|
Change in net unearned premium reserves
|
|
(26,573
|
)
|
|
(33,263
|
)
|
||
|
Net premiums earned
|
|
138,112
|
|
|
94,793
|
|
||
|
Net investment income (loss)
|
|
28,435
|
|
|
(24,829
|
)
|
||
|
Other income (expense), net
|
|
(271
|
)
|
|
1,588
|
|
||
|
Total revenues
|
|
166,276
|
|
|
71,552
|
|
||
|
Expenses
|
|
|
|
|
||||
|
Loss and loss adjustment expenses incurred, net
|
|
90,668
|
|
|
63,207
|
|
||
|
Acquisition costs, net
|
|
38,963
|
|
|
26,841
|
|
||
|
General and administrative expenses
|
|
6,999
|
|
|
6,160
|
|
||
|
Total expenses
|
|
136,630
|
|
|
96,208
|
|
||
|
Income (loss) before income tax
|
|
29,646
|
|
|
(24,656
|
)
|
||
|
Income tax (expense) benefit
|
|
(204
|
)
|
|
215
|
|
||
|
Net income (loss) including non-controlling interest
|
|
29,442
|
|
|
(24,441
|
)
|
||
|
Loss (income) attributable to non-controlling interest in joint venture
|
|
(773
|
)
|
|
394
|
|
||
|
Net income (loss)
|
|
$
|
28,669
|
|
|
$
|
(24,047
|
)
|
|
Earnings (loss) per share
|
|
|
|
|
||||
|
Basic
|
|
$
|
0.77
|
|
|
$
|
(0.65
|
)
|
|
Diluted
|
|
$
|
0.77
|
|
|
$
|
(0.65
|
)
|
|
Weighted average number of ordinary shares used in the determination of earnings and loss per share
|
|
|
|
|
||||
|
Basic
|
|
37,107,039
|
|
|
37,173,008
|
|
||
|
Diluted
|
|
37,422,921
|
|
|
37,173,008
|
|
||
|
|
Ordinary share capital
|
|
Additional paid-in capital
|
|
Retained earnings
|
|
Shareholders' equity attributable to shareholders
|
|
Non-controlling
interest in joint venture |
|
Total equity
|
||||||||||||
|
Balance at December 31, 2014
|
$
|
3,738
|
|
|
$
|
500,553
|
|
|
$
|
660,860
|
|
|
$
|
1,165,151
|
|
|
$
|
28,890
|
|
|
$
|
1,194,041
|
|
|
Issue of Class A ordinary shares, net of forfeitures
|
14
|
|
|
—
|
|
|
—
|
|
|
14
|
|
|
—
|
|
|
14
|
|
||||||
|
Share-based compensation expense, net of forfeitures
|
—
|
|
|
1,034
|
|
|
—
|
|
|
1,034
|
|
|
—
|
|
|
1,034
|
|
||||||
|
Income (loss) attributable to non-controlling interest in joint venture
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(394
|
)
|
|
(394
|
)
|
||||||
|
Net income (loss)
|
—
|
|
|
—
|
|
|
(24,047
|
)
|
|
(24,047
|
)
|
|
—
|
|
|
(24,047
|
)
|
||||||
|
Balance at March 31, 2015
|
$
|
3,752
|
|
|
$
|
501,587
|
|
|
$
|
636,813
|
|
|
$
|
1,142,152
|
|
|
$
|
28,496
|
|
|
$
|
1,170,648
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Balance at December 31, 2015
|
$
|
3,703
|
|
|
$
|
496,401
|
|
|
$
|
325,287
|
|
|
$
|
825,391
|
|
|
$
|
23,382
|
|
|
$
|
848,773
|
|
|
Issue of Class A ordinary shares, net of forfeitures
|
20
|
|
|
—
|
|
|
—
|
|
|
20
|
|
|
—
|
|
|
20
|
|
||||||
|
Share-based compensation expense, net of forfeitures
|
—
|
|
|
740
|
|
|
—
|
|
|
740
|
|
|
—
|
|
|
740
|
|
||||||
|
Income (loss) attributable to non-controlling interest in joint venture
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
773
|
|
|
773
|
|
||||||
|
Net income (loss)
|
—
|
|
|
—
|
|
|
28,669
|
|
|
28,669
|
|
|
—
|
|
|
28,669
|
|
||||||
|
Balance at March 31, 2016
|
$
|
3,723
|
|
|
$
|
497,141
|
|
|
$
|
353,956
|
|
|
$
|
854,820
|
|
|
$
|
24,155
|
|
|
$
|
878,975
|
|
|
|
Three months ended March 31
|
||||||
|
|
2016
|
|
2015
|
||||
|
Cash provided by (used in) operating activities
|
|
|
|
||||
|
Net income (loss)
|
$
|
28,669
|
|
|
$
|
(24,047
|
)
|
|
Adjustments to reconcile net income or loss to net cash provided by (used in) operating activities
|
|
|
|
||||
|
Net change in unrealized gains and losses on investments and financial contracts
|
(78,700
|
)
|
|
29,850
|
|
||
|
Net realized gains (losses) on investments and financial contracts
|
38,611
|
|
|
(25,010
|
)
|
||
|
Foreign exchange (gains) losses on investments
|
4,112
|
|
|
7,973
|
|
||
|
Income (loss) attributable to non-controlling interest in joint venture
|
773
|
|
|
(394
|
)
|
||
|
Share-based compensation expense, net of forfeitures
|
760
|
|
|
1,048
|
|
||
|
Depreciation expense
|
102
|
|
|
101
|
|
||
|
Net change in
|
|
|
|
||||
|
Reinsurance balances receivable
|
(58,922
|
)
|
|
(32,770
|
)
|
||
|
Loss and loss adjustment expenses recoverable
|
(180
|
)
|
|
(203
|
)
|
||
|
Deferred acquisition costs, net
|
(8,361
|
)
|
|
(8,134
|
)
|
||
|
Unearned premiums ceded
|
446
|
|
|
357
|
|
||
|
Other assets
|
(427
|
)
|
|
(651
|
)
|
||
|
Loss and loss adjustment expense reserves
|
35,135
|
|
|
(3,933
|
)
|
||
|
Unearned premium reserves
|
25,965
|
|
|
32,245
|
|
||
|
Reinsurance balances payable
|
1,378
|
|
|
1,138
|
|
||
|
Funds withheld
|
(107
|
)
|
|
212
|
|
||
|
Other liabilities
|
(579
|
)
|
|
4,053
|
|
||
|
Performance compensation payable to related party
|
3,081
|
|
|
—
|
|
||
|
Net cash provided by (used in) operating activities
|
(8,244
|
)
|
|
(18,165
|
)
|
||
|
Investing activities
|
|
|
|
||||
|
Purchases of investments, trading
|
(423,065
|
)
|
|
(251,068
|
)
|
||
|
Sales of investments, trading
|
308,059
|
|
|
252,857
|
|
||
|
Payments for financial contracts
|
(29,976
|
)
|
|
(3,999
|
)
|
||
|
Proceeds from financial contracts
|
9,123
|
|
|
8,294
|
|
||
|
Securities sold, not yet purchased
|
290,478
|
|
|
391,768
|
|
||
|
Dispositions of securities sold, not yet purchased
|
(276,369
|
)
|
|
(182,793
|
)
|
||
|
Change in due to prime brokers
|
148,028
|
|
|
44,590
|
|
||
|
Change in restricted cash and cash equivalents, net
|
76,329
|
|
|
(239,358
|
)
|
||
|
Change in notes receivable, net
|
(10,391
|
)
|
|
(2,690
|
)
|
||
|
Net cash provided by (used in) investing activities
|
92,216
|
|
|
17,601
|
|
||
|
Net increase (decrease) in cash and cash equivalents
|
83,972
|
|
|
(564
|
)
|
||
|
Cash and cash equivalents at beginning of the period
|
112,162
|
|
|
12,030
|
|
||
|
Cash and cash equivalents at end of the period
|
$
|
196,134
|
|
|
$
|
11,466
|
|
|
Supplementary information
|
|
|
|
||||
|
Interest paid in cash
|
$
|
2,576
|
|
|
$
|
3,741
|
|
|
Income tax paid in cash
|
—
|
|
|
—
|
|
||
|
Non-cash transfer to notes receivable
|
—
|
|
|
25,859
|
|
||
|
|
Three months ended March 31
|
||||
|
|
2016
|
|
2015
|
||
|
Weighted average shares outstanding - basic
|
37,107,039
|
|
|
37,173,008
|
|
|
Effect of dilutive employee and director share-based awards
|
315,882
|
|
|
—
|
|
|
Weighted average shares outstanding - diluted
|
37,422,921
|
|
|
37,173,008
|
|
|
Anti-dilutive stock options outstanding
|
485,991
|
|
|
71,821
|
|
|
Participating securities excluded from calculation of loss per share
|
—
|
|
|
322,971
|
|
|
|
|
Fair value measurements as of March 31, 2016
|
||||||||||||||
|
Description
|
|
Quoted prices in
active markets (Level 1) |
|
Significant other
observable inputs (Level 2) |
|
Significant
unobservable inputs (Level 3) |
|
Total
|
||||||||
|
Assets:
|
|
($ in thousands)
|
||||||||||||||
|
Debt instruments
|
|
$
|
—
|
|
|
$
|
73,383
|
|
|
$
|
496
|
|
|
$
|
73,879
|
|
|
Listed equity securities
|
|
928,903
|
|
|
5,329
|
|
|
—
|
|
|
934,232
|
|
||||
|
Commodities
|
|
172,661
|
|
|
—
|
|
|
—
|
|
|
172,661
|
|
||||
|
Private and unlisted equity securities
|
|
—
|
|
|
—
|
|
|
5,931
|
|
|
5,931
|
|
||||
|
Private equity funds measured at net asset value
(1)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11,924
|
|
||||
|
Total investments
|
|
$
|
1,101,564
|
|
|
$
|
78,712
|
|
|
$
|
6,427
|
|
|
$
|
1,198,627
|
|
|
Financial contracts receivable
|
|
$
|
15
|
|
|
$
|
13,271
|
|
|
$
|
—
|
|
|
$
|
13,286
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Liabilities:
|
|
|
|
|
|
|
|
|
||||||||
|
Listed equity securities, sold not yet purchased
|
|
$
|
(829,394
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(829,394
|
)
|
|
Debt instruments, sold not yet purchased
|
|
—
|
|
|
(46,854
|
)
|
|
—
|
|
|
(46,854
|
)
|
||||
|
Securities sold, not yet purchased, at fair value
|
|
$
|
(829,394
|
)
|
|
$
|
(46,854
|
)
|
|
$
|
—
|
|
|
$
|
(876,248
|
)
|
|
Financial contracts payable
|
|
$
|
(206
|
)
|
|
$
|
(8,900
|
)
|
|
$
|
—
|
|
|
$
|
(9,106
|
)
|
|
|
|
Fair value measurements as of December 31, 2015
|
||||||||||||||
|
Description
|
|
Quoted prices in
active markets (Level 1) |
|
Significant other
observable inputs (Level 2) |
|
Significant
unobservable inputs (Level 3) |
|
Total
|
||||||||
|
Assets:
|
|
($ in thousands)
|
||||||||||||||
|
Debt instruments
|
|
$
|
—
|
|
|
$
|
38,582
|
|
|
$
|
505
|
|
|
$
|
39,087
|
|
|
Listed equity securities
|
|
900,369
|
|
|
5,625
|
|
|
—
|
|
|
905,994
|
|
||||
|
Commodities
|
|
98,046
|
|
|
—
|
|
|
—
|
|
|
98,046
|
|
||||
|
Private and unlisted equity securities
|
|
—
|
|
|
—
|
|
|
8,452
|
|
|
8,452
|
|
||||
|
Private equity funds measured at net asset value
(1)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
12,585
|
|
||||
|
|
|
$
|
998,415
|
|
|
$
|
44,207
|
|
|
$
|
8,957
|
|
|
$
|
1,064,164
|
|
|
Financial contracts receivable
|
|
$
|
20
|
|
|
$
|
13,195
|
|
|
$
|
—
|
|
|
$
|
13,215
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Liabilities:
|
|
|
|
|
|
|
|
|
||||||||
|
Listed equity securities, sold not yet purchased
|
|
$
|
(808,481
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(808,481
|
)
|
|
Debt instruments, sold not yet purchased
|
|
—
|
|
|
(74,425
|
)
|
|
—
|
|
|
(74,425
|
)
|
||||
|
Securities sold, not yet purchased, at fair value
|
|
$
|
(808,481
|
)
|
|
$
|
(74,425
|
)
|
|
$
|
—
|
|
|
$
|
(882,906
|
)
|
|
Financial contracts payable
|
|
$
|
(488
|
)
|
|
$
|
(27,757
|
)
|
|
$
|
—
|
|
|
$
|
(28,245
|
)
|
|
|
|
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
|
||||||||||
|
|
|
Three months ended March 31, 2016
|
||||||||||
|
|
|
Assets
|
||||||||||
|
|
|
Debt instruments
|
|
Private and unlisted equity securities
|
|
Total
|
||||||
|
|
|
($ in thousands)
|
||||||||||
|
Beginning balance
|
|
$
|
505
|
|
|
$
|
8,452
|
|
|
$
|
8,957
|
|
|
Purchases
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Sales
|
|
—
|
|
|
(2,539
|
)
|
|
(2,539
|
)
|
|||
|
Issuances
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Settlements
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Total realized and unrealized gains (losses) and amortization included in earnings, net
|
|
(9
|
)
|
|
18
|
|
|
9
|
|
|||
|
Transfers into Level 3
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Transfers out of Level 3
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Ending balance
|
|
$
|
496
|
|
|
$
|
5,931
|
|
|
$
|
6,427
|
|
|
|
|
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
|
||||||||||||||
|
|
|
Three months ended March 31, 2015
|
||||||||||||||
|
|
|
Assets
|
||||||||||||||
|
|
|
Debt instruments
|
|
Private and unlisted equity securities
|
|
Financial contracts receivable
|
|
Total
|
||||||||
|
|
|
($ in thousands)
|
||||||||||||||
|
Beginning balance
|
|
$
|
22,259
|
|
|
$
|
6,449
|
|
|
$
|
—
|
|
|
$
|
28,708
|
|
|
Purchases
|
|
—
|
|
|
—
|
|
|
2,340
|
|
|
2,340
|
|
||||
|
Sales
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Issuances
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Settlements
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Total realized and unrealized gains (losses) and amortization included in earnings, net
|
|
1
|
|
|
—
|
|
|
(577
|
)
|
|
(576
|
)
|
||||
|
Transfers into Level 3
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Transfers out of Level 3
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Ending balance
|
|
$
|
22,260
|
|
|
$
|
6,449
|
|
|
$
|
1,763
|
|
|
$
|
30,472
|
|
|
|
|
Cost/amortized cost
|
|
Unrealized gains
|
|
Unrealized losses
|
|
Fair
value |
||||||||
|
|
|
($ in thousands)
|
||||||||||||||
|
Corporate debt – U.S.
|
|
$
|
35,468
|
|
|
$
|
3,035
|
|
|
$
|
(5,430
|
)
|
|
$
|
33,073
|
|
|
Corporate debt – Non U.S.
|
|
2,109
|
|
|
—
|
|
|
(2,047
|
)
|
|
62
|
|
||||
|
Sovereign debt – U.S.
|
|
20,534
|
|
|
354
|
|
|
—
|
|
|
20,888
|
|
||||
|
Sovereign debt – Non U.S.
|
|
17,688
|
|
|
2,168
|
|
|
—
|
|
|
19,856
|
|
||||
|
Total debt instruments
|
|
$
|
75,799
|
|
|
$
|
5,557
|
|
|
$
|
(7,477
|
)
|
|
$
|
73,879
|
|
|
|
|
Cost/amortized cost
|
|
Unrealized gains
|
|
Unrealized losses
|
|
Fair
value |
||||||||
|
|
|
($ in thousands)
|
||||||||||||||
|
Corporate debt – U.S.
|
|
$
|
25,674
|
|
|
$
|
155
|
|
|
$
|
(5,519
|
)
|
|
$
|
20,310
|
|
|
Corporate debt – Non U.S.
|
|
2,109
|
|
|
—
|
|
|
(1,795
|
)
|
|
314
|
|
||||
|
Sovereign debt – Non U.S.
|
|
17,688
|
|
|
1,225
|
|
|
(450
|
)
|
|
18,463
|
|
||||
|
Total debt instruments
|
|
$
|
45,471
|
|
|
$
|
1,380
|
|
|
$
|
(7,764
|
)
|
|
$
|
39,087
|
|
|
|
|
March 31, 2016
|
|
December 31, 2015
|
||||||||||||
|
|
|
Cost/
amortized cost |
|
Fair
value |
|
Cost/
amortized cost |
|
Fair
value |
||||||||
|
|
|
($ in thousands)
|
||||||||||||||
|
Within one year
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
From one to five years
|
|
15,198
|
|
|
11,127
|
|
|
4,202
|
|
|
4,129
|
|
||||
|
From five to ten years
|
|
21,428
|
|
|
21,512
|
|
|
18,840
|
|
|
14,780
|
|
||||
|
More than ten years
|
|
39,173
|
|
|
41,240
|
|
|
22,429
|
|
|
20,178
|
|
||||
|
|
|
$
|
75,799
|
|
|
$
|
73,879
|
|
|
$
|
45,471
|
|
|
$
|
39,087
|
|
|
|
|
Cost
|
|
Unrealized
gains |
|
Unrealized
losses |
|
Fair
value |
||||||||
|
|
|
($ in thousands)
|
||||||||||||||
|
Equities – listed
|
|
$
|
996,856
|
|
|
$
|
87,631
|
|
|
$
|
(167,049
|
)
|
|
$
|
917,438
|
|
|
Exchange traded funds
|
|
17,986
|
|
|
—
|
|
|
(1,192
|
)
|
|
16,794
|
|
||||
|
Total equity securities
|
|
$
|
1,014,842
|
|
|
$
|
87,631
|
|
|
$
|
(168,241
|
)
|
|
$
|
934,232
|
|
|
|
|
Cost
|
|
Unrealized
gains |
|
Unrealized
losses |
|
Fair
value |
||||||||
|
|
|
($ in thousands)
|
||||||||||||||
|
Equities – listed
|
|
$
|
1,011,424
|
|
|
$
|
67,114
|
|
|
$
|
(187,885
|
)
|
|
$
|
890,653
|
|
|
Exchange traded funds
|
|
31,570
|
|
|
—
|
|
|
(16,229
|
)
|
|
15,341
|
|
||||
|
Total equity securities
|
|
$
|
1,042,994
|
|
|
$
|
67,114
|
|
|
$
|
(204,114
|
)
|
|
$
|
905,994
|
|
|
|
|
Cost
|
|
Unrealized
gains |
|
Unrealized
losses |
|
Fair
value |
||||||||
|
|
|
($ in thousands)
|
||||||||||||||
|
Commodities
|
|
$
|
155,693
|
|
|
$
|
16,968
|
|
|
$
|
—
|
|
|
$
|
172,661
|
|
|
Private and unlisted equity securities
|
|
14,034
|
|
|
3,821
|
|
|
—
|
|
|
17,855
|
|
||||
|
|
|
$
|
169,727
|
|
|
$
|
20,789
|
|
|
$
|
—
|
|
|
$
|
190,516
|
|
|
|
|
Cost
|
|
Unrealized
gains |
|
Unrealized
losses |
|
Fair
value |
||||||||
|
|
|
($ in thousands)
|
||||||||||||||
|
Commodities
|
|
$
|
102,092
|
|
|
$
|
—
|
|
|
$
|
(4,046
|
)
|
|
$
|
98,046
|
|
|
Private and unlisted equity securities
|
|
18,720
|
|
|
3,491
|
|
|
(1,174
|
)
|
|
21,037
|
|
||||
|
|
|
$
|
120,812
|
|
|
$
|
3,491
|
|
|
$
|
(5,220
|
)
|
|
$
|
119,083
|
|
|
|
|
Proceeds
|
|
Unrealized gains
|
|
Unrealized losses
|
|
Fair value
|
||||||||
|
|
|
($ in thousands)
|
||||||||||||||
|
Equities – listed
|
|
$
|
(812,542
|
)
|
|
$
|
71,809
|
|
|
$
|
(79,082
|
)
|
|
$
|
(819,815
|
)
|
|
Exchange traded funds
|
|
(9,572
|
)
|
|
—
|
|
|
(8
|
)
|
|
(9,580
|
)
|
||||
|
Sovereign debt – Non U.S.
|
|
(41,185
|
)
|
|
—
|
|
|
(5,668
|
)
|
|
(46,853
|
)
|
||||
|
|
|
$
|
(863,299
|
)
|
|
$
|
71,809
|
|
|
$
|
(84,758
|
)
|
|
$
|
(876,248
|
)
|
|
|
|
Proceeds
|
|
Unrealized gains
|
|
Unrealized losses
|
|
Fair value
|
||||||||
|
|
|
($ in thousands)
|
||||||||||||||
|
Equities – listed
|
|
$
|
(803,842
|
)
|
|
$
|
102,469
|
|
|
$
|
(94,681
|
)
|
|
$
|
(796,054
|
)
|
|
Exchange traded funds
|
|
(9,572
|
)
|
|
—
|
|
|
(2,855
|
)
|
|
(12,427
|
)
|
||||
|
Sovereign debt – Non U.S.
|
|
(77,443
|
)
|
|
3,018
|
|
|
—
|
|
|
(74,425
|
)
|
||||
|
|
|
$
|
(890,857
|
)
|
|
$
|
105,487
|
|
|
$
|
(97,536
|
)
|
|
$
|
(882,906
|
)
|
|
Financial Contracts
|
|
Listing
currency (1) |
|
Notional amount of
underlying instruments |
|
Fair value of net assets
(obligations) on financial contracts |
|||
|
|
|
|
|
($ in thousands)
|
|||||
|
Financial contracts receivable
|
|
|
|
|
|
|
|||
|
Commodity Swaps
|
|
USD
|
|
59,161
|
|
|
$
|
885
|
|
|
Put options
(2)
|
|
USD
|
|
92,290
|
|
|
3,064
|
|
|
|
Total return swaps – equities
|
|
EUR/GBP/HKD/RON/USD
|
|
53,238
|
|
|
9,207
|
|
|
|
Warrants and rights on listed equities
|
|
EUR/USD
|
|
176
|
|
|
130
|
|
|
|
Total financial contracts receivable, at fair value
|
|
|
|
|
|
$
|
13,286
|
|
|
|
Financial contracts payable
|
|
|
|
|
|
|
|||
|
Forwards
|
|
KRW
|
|
2,926
|
|
|
$
|
(160
|
)
|
|
Futures
|
|
USD
|
|
25,766
|
|
|
(206
|
)
|
|
|
Total return swaps – equities
|
|
EUR/GBP/MXN/USD
|
|
33,887
|
|
|
(8,740
|
)
|
|
|
Total financial contracts payable, at fair value
|
|
|
|
|
|
$
|
(9,106
|
)
|
|
|
Financial Contracts
|
|
Listing currency
(1)
|
|
Notional amount of
underlying instruments |
|
Fair value of net assets
(obligations) on financial contracts |
|||
|
|
|
|
|
($ in thousands)
|
|||||
|
Financial contracts receivable
|
|
|
|
|
|
|
|||
|
Call options
(2)
|
|
USD
|
|
47,259
|
|
|
$
|
657
|
|
|
Put options
(3)
|
|
USD
|
|
147,326
|
|
|
8,790
|
|
|
|
Total return swaps – equities
|
|
EUR/GBP/USD
|
|
50,205
|
|
|
3,748
|
|
|
|
Warrants and rights on listed equities
|
|
EUR
|
|
59
|
|
|
20
|
|
|
|
Total financial contracts receivable, at fair value
|
|
|
|
|
|
$
|
13,215
|
|
|
|
Financial contracts payable
|
|
|
|
|
|
|
|||
|
Call options
|
|
USD
|
|
2,601
|
|
|
$
|
(64
|
)
|
|
Commodity Swaps
|
|
USD
|
|
42,160
|
|
|
(12,784
|
)
|
|
|
Forwards
|
|
KRW
|
|
2,908
|
|
|
(22
|
)
|
|
|
Futures
|
|
USD
|
|
21,195
|
|
|
(488
|
)
|
|
|
Total return swaps – equities
|
|
EUR/GBP/HKD/RON/MXN/USD
|
|
71,874
|
|
|
(14,887
|
)
|
|
|
Total financial contracts payable, at fair value
|
|
|
|
|
|
$
|
(28,245
|
)
|
|
|
Derivatives not designated as hedging instruments
|
|
Location of gains and losses on derivatives recognized in income
|
|
Gain (loss) on derivatives recognized in income
|
||||||
|
|
|
|
|
Three months ended March 31
|
||||||
|
|
|
|
|
2016
|
|
2015
|
||||
|
|
|
|
|
($ in thousands)
|
||||||
|
Credit default swaps, purchased – corporate debt
|
|
Net investment income (loss)
|
|
$
|
—
|
|
|
$
|
(55
|
)
|
|
Credit default swaps, purchased – sovereign debt
|
|
Net investment income (loss)
|
|
—
|
|
|
(31
|
)
|
||
|
Forwards
|
|
Net investment income (loss)
|
|
(81
|
)
|
|
136
|
|
||
|
Futures
|
|
Net investment income (loss)
|
|
984
|
|
|
(2,077
|
)
|
||
|
Options, warrants, and rights
|
|
Net investment income (loss)
|
|
(2,803
|
)
|
|
(2,474
|
)
|
||
|
Commodity swaps
|
|
Net investment income (loss)
|
|
(5,565
|
)
|
|
—
|
|
||
|
Total return swaps – equities
|
|
Net investment income (loss)
|
|
6,919
|
|
|
4,223
|
|
||
|
Weather derivative swap
|
|
Other income (expense), net
|
|
—
|
|
|
(577
|
)
|
||
|
Total
|
|
|
|
$
|
(546
|
)
|
|
$
|
(855
|
)
|
|
2016
|
|
Three months ended March 31
|
||||||
|
Derivatives not designated as hedging instruments (notional amounts)
|
|
Entered
|
|
Exited
|
||||
|
|
|
($ in thousands)
|
||||||
|
Forwards
|
|
$
|
—
|
|
|
$
|
63
|
|
|
Futures
|
|
174,721
|
|
|
169,710
|
|
||
|
Options, warrants and rights
(1)
|
|
133,333
|
|
|
175,651
|
|
||
|
Commodity swaps
|
|
75,566
|
|
|
54,374
|
|
||
|
Total return swaps
|
|
1,483
|
|
|
28,271
|
|
||
|
Total
|
|
$
|
385,103
|
|
|
$
|
428,069
|
|
|
2015
|
|
Three months ended March 31
|
||||||
|
Derivatives not designated as hedging instruments (notional amounts)
|
|
Entered
|
|
Exited
|
||||
|
|
|
($ in thousands)
|
||||||
|
Forwards
|
|
$
|
—
|
|
|
$
|
4,725
|
|
|
Futures
|
|
84,989
|
|
|
56,748
|
|
||
|
Options, warrants and rights
(1)
|
|
—
|
|
|
69,777
|
|
||
|
Total return swaps
|
|
14,900
|
|
|
39,748
|
|
||
|
Weather derivative swap
|
|
2,340
|
|
|
—
|
|
||
|
Total
|
|
$
|
102,229
|
|
|
$
|
170,998
|
|
|
March 31, 2016
|
|
(i)
|
|
(ii)
|
|
(iii) = (i) - (ii)
|
|
(iv) Gross amounts not offset in the balance sheet
|
|
(v) = (iii) + (iv)
|
||||||||||||||
|
Description
|
|
Gross amounts of recognized assets (liabilities)
|
|
Gross amounts offset in the balance sheet
|
|
Net amounts of assets (liabilities) presented in the balance sheet
|
|
Financial instruments available for offset
|
|
Cash collateral (received) pledged
|
|
Net amount of asset (liability)
|
||||||||||||
|
|
|
($ in thousands)
|
||||||||||||||||||||||
|
Financial contracts receivable
|
|
$
|
13,286
|
|
|
$
|
—
|
|
|
$
|
13,286
|
|
|
$
|
(6,239
|
)
|
|
$
|
(3,748
|
)
|
|
$
|
3,299
|
|
|
Financial contracts payable
|
|
(9,106
|
)
|
|
—
|
|
|
(9,106
|
)
|
|
6,239
|
|
|
2,867
|
|
|
—
|
|
||||||
|
December 31, 2015
|
|
(i)
|
|
(ii)
|
|
(iii) = (i) - (ii)
|
|
(iv) Gross amounts not offset in the balance sheet
|
|
(v) = (iii) + (iv)
|
||||||||||||||
|
Description
|
|
Gross amounts of recognized assets (liabilities)
|
|
Gross amounts offset in the balance sheet
|
|
Net amounts of assets (liabilities) presented in the balance sheet
|
|
Financial instruments available for offset
|
|
Cash collateral (received) pledged
|
|
Net amount of asset (liability)
|
||||||||||||
|
|
|
($ in thousands)
|
||||||||||||||||||||||
|
Financial contracts receivable
|
|
$
|
13,215
|
|
|
$
|
—
|
|
|
$
|
13,215
|
|
|
$
|
(8,937
|
)
|
|
$
|
(2,036
|
)
|
|
$
|
2,242
|
|
|
Financial contracts payable
|
|
(28,245
|
)
|
|
—
|
|
|
(28,245
|
)
|
|
8,937
|
|
|
19,308
|
|
|
—
|
|
||||||
|
|
|
Number of
non-vested restricted shares |
|
Weighted
average grant date fair value |
|||
|
Balance at December 31, 2015
|
|
307,013
|
|
|
$
|
29.74
|
|
|
Granted
|
|
149,332
|
|
|
21.56
|
|
|
|
Vested
|
|
(93,193
|
)
|
|
24.43
|
|
|
|
Forfeited
|
|
(4,177
|
)
|
|
32.62
|
|
|
|
Balance at March 31, 2016
|
|
358,975
|
|
|
$
|
27.68
|
|
|
|
|
Number of
options |
|
Weighted
average exercise price |
|
Weighted
average grant date fair value |
|||||
|
Balance at December 31, 2015
|
|
906,991
|
|
|
$
|
19.78
|
|
|
$
|
8.53
|
|
|
Granted
|
|
—
|
|
|
—
|
|
|
—
|
|
||
|
Exercised
|
|
(156,000
|
)
|
|
11.65
|
|
|
5.86
|
|
||
|
Forfeited
|
|
—
|
|
|
—
|
|
|
—
|
|
||
|
Expired
|
|
—
|
|
|
—
|
|
|
—
|
|
||
|
Balance at March 31, 2016
|
|
750,991
|
|
|
$
|
21.47
|
|
|
$
|
9.09
|
|
|
|
|
Number of
non-vested RSUs |
|
Weighted
average grant date fair value |
|||
|
Balance at December 31, 2015
|
|
22,170
|
|
|
$
|
30.55
|
|
|
Granted
|
|
7,444
|
|
|
21.56
|
|
|
|
Vested
|
|
(736
|
)
|
|
24.43
|
|
|
|
Forfeited
|
|
(11,330
|
)
|
|
29.71
|
|
|
|
Balance at March 31, 2016
|
|
17,548
|
|
|
$
|
27.54
|
|
|
|
|
Facility
|
|
Termination Date
|
|
Notice period required for termination
|
||
|
|
|
($ in thousands)
|
|
|
|
|
||
|
Bank of America, N.A.
|
|
$
|
120,000
|
|
|
July 11, 2016
|
|
90 days prior to termination date
|
|
Butterfield Bank (Cayman) Limited
|
|
100,000
|
|
|
June 30, 2016
|
|
90 days prior to termination date
|
|
|
Citibank Europe plc
|
|
400,000
|
|
|
October 11, 2016
|
|
120 days prior to termination date
|
|
|
JP Morgan Chase Bank N.A.
|
|
100,000
|
|
|
January 27, 2017
|
|
120 days prior to termination date
|
|
|
|
|
$
|
720,000
|
|
|
|
|
|
|
|
2016
|
|
2017
|
|
2018
|
|
2019
|
|
2020
|
|
Thereafter
|
|
Total
|
||||||||||||||
|
|
($ in thousands)
|
||||||||||||||||||||||||||
|
Operating lease obligations
|
$
|
414
|
|
|
$
|
552
|
|
|
$
|
319
|
|
|
$
|
86
|
|
|
$
|
86
|
|
|
$
|
32
|
|
|
$
|
1,489
|
|
|
Private equity and limited partnerships
(1)
|
5,282
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,282
|
|
|||||||
|
|
$
|
5,696
|
|
|
$
|
552
|
|
|
$
|
319
|
|
|
$
|
86
|
|
|
$
|
86
|
|
|
$
|
32
|
|
|
$
|
6,771
|
|
|
|
|
Three months ended March 31
|
||||||||||||
|
|
|
2016
|
|
2015
|
||||||||||
|
|
|
($ in thousands)
|
||||||||||||
|
Property
|
|
|
|
|
|
|
|
|
||||||
|
Aviation
|
|
$
|
214
|
|
|
0.1
|
%
|
|
$
|
266
|
|
|
0.2
|
%
|
|
Commercial
|
|
5,637
|
|
|
3.4
|
|
|
6,449
|
|
|
5.0
|
|
||
|
Energy
|
|
1,768
|
|
|
1.1
|
|
|
1,670
|
|
|
1.3
|
|
||
|
Motor physical damage
|
|
9,365
|
|
|
5.6
|
|
|
7,593
|
|
|
5.9
|
|
||
|
Personal
|
|
26,648
|
|
|
16.0
|
|
|
22,016
|
|
|
17.0
|
|
||
|
Total Property
|
|
43,632
|
|
|
26.2
|
|
|
37,994
|
|
|
29.4
|
|
||
|
Casualty
|
|
|
|
|
|
|
|
|
||||||
|
General liability
|
|
8,411
|
|
|
5.0
|
|
|
6,398
|
|
|
4.9
|
|
||
|
Marine liability
|
|
3,652
|
|
|
2.2
|
|
|
3,934
|
|
|
3.0
|
|
||
|
Motor liability
|
|
49,568
|
|
|
29.7
|
|
|
43,331
|
|
|
33.4
|
|
||
|
Professional liability
|
|
13,890
|
|
|
8.3
|
|
|
15,059
|
|
|
11.6
|
|
||
|
Total Casualty
|
|
75,521
|
|
|
45.2
|
|
|
68,722
|
|
|
52.9
|
|
||
|
Specialty
|
|
|
|
|
|
|
|
|
||||||
|
Financial
|
|
15,678
|
|
|
9.4
|
|
|
1,556
|
|
|
1.2
|
|
||
|
Health
|
|
27,195
|
|
|
16.3
|
|
|
20,681
|
|
|
15.9
|
|
||
|
Workers’ compensation
|
|
4,766
|
|
|
2.9
|
|
|
729
|
|
|
0.6
|
|
||
|
Total Specialty
|
|
47,639
|
|
|
28.6
|
|
|
22,966
|
|
|
17.7
|
|
||
|
|
|
$
|
166,792
|
|
|
100.0
|
%
|
|
$
|
129,682
|
|
|
100.0
|
%
|
|
|
|
Three months ended March 31
|
||||||||||||
|
|
|
2016
|
|
2015
|
||||||||||
|
|
|
($ in thousands)
|
||||||||||||
|
U.S. and Caribbean
|
|
$
|
130,744
|
|
|
78.4
|
%
|
|
$
|
94,396
|
|
|
72.8
|
%
|
|
Worldwide
(1)
|
|
34,358
|
|
|
20.6
|
|
|
33,304
|
|
|
25.7
|
|
||
|
Europe
|
|
1,910
|
|
|
1.1
|
|
|
1,933
|
|
|
1.5
|
|
||
|
Asia
(2)
|
|
(220
|
)
|
|
(0.1
|
)
|
|
49
|
|
|
—
|
|
||
|
|
|
$
|
166,792
|
|
|
100.0
|
%
|
|
$
|
129,682
|
|
|
100.0
|
%
|
|
|
March 31, 2016
|
|
December 31, 2015
|
|
September 30, 2015
|
|
June 30, 2015
|
|
March 31, 2015
|
||||||||||
|
|
($ in thousands, except per share and share amounts)
|
||||||||||||||||||
|
Basic adjusted and fully diluted adjusted book value per share numerator:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Total equity (U.S. GAAP)
|
$
|
878,975
|
|
|
$
|
848,773
|
|
|
$
|
891,616
|
|
|
$
|
1,127,496
|
|
|
$
|
1,170,648
|
|
|
Less: Non-controlling interest in joint venture
|
(24,155
|
)
|
|
(23,382
|
)
|
|
(24,263
|
)
|
|
(28,172
|
)
|
|
(28,496
|
)
|
|||||
|
Basic adjusted book value per share numerator
|
854,820
|
|
|
825,391
|
|
|
867,353
|
|
|
1,099,324
|
|
|
1,142,152
|
|
|||||
|
Add: Proceeds from in-the-money stock options issued and outstanding
|
3,459
|
|
|
11,553
|
|
|
13,260
|
|
|
15,236
|
|
|
16,302
|
|
|||||
|
Fully diluted adjusted book value per share numerator
|
$
|
858,279
|
|
|
$
|
836,944
|
|
|
$
|
880,613
|
|
|
$
|
1,114,560
|
|
|
$
|
1,158,454
|
|
|
Basic adjusted and fully diluted adjusted book value per share denominator:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Ordinary shares issued and outstanding for basic adjusted book value per share denominator
|
37,232,537
|
|
|
37,027,467
|
|
|
37,027,467
|
|
|
37,464,546
|
|
|
37,521,627
|
|
|||||
|
Add: In-the-money stock options and RSUs issued and outstanding
|
282,548
|
|
|
717,340
|
|
|
777,340
|
|
|
880,917
|
|
|
976,917
|
|
|||||
|
Fully diluted adjusted book value per share denominator
|
37,515,085
|
|
|
37,744,807
|
|
|
37,804,807
|
|
|
38,345,463
|
|
|
38,498,544
|
|
|||||
|
Basic adjusted book value per share
|
$
|
22.96
|
|
|
$
|
22.29
|
|
|
$
|
23.42
|
|
|
$
|
29.34
|
|
|
$
|
30.44
|
|
|
Fully diluted adjusted book value per share
|
22.88
|
|
|
22.17
|
|
|
23.29
|
|
|
29.07
|
|
|
30.09
|
|
|||||
|
|
|
Three months ended March 31
|
||||||||||||
|
|
|
2016
|
|
2015
|
||||||||||
|
|
|
($ in thousands)
|
||||||||||||
|
Frequency
|
|
$
|
152,809
|
|
|
91.6
|
%
|
|
$
|
113,900
|
|
|
87.8
|
%
|
|
Severity
|
|
13,983
|
|
|
8.4
|
|
|
15,782
|
|
|
12.2
|
|
||
|
Total
|
|
$
|
166,792
|
|
|
100.0
|
%
|
|
$
|
129,682
|
|
|
100.0
|
%
|
|
|
|
Three months ended March 31
|
||||||||||||
|
|
|
2016
|
|
2015
|
||||||||||
|
|
|
($ in thousands)
|
||||||||||||
|
Frequency
|
|
$
|
150,703
|
|
|
91.5
|
%
|
|
$
|
112,275
|
|
|
87.7
|
%
|
|
Severity
|
|
13,982
|
|
|
8.5
|
|
|
15,781
|
|
|
12.3
|
|
||
|
Total
|
|
$
|
164,685
|
|
|
100.0
|
%
|
|
$
|
128,056
|
|
|
100.0
|
%
|
|
|
|
Three months ended March 31
|
||||||||||||
|
|
|
2016
|
|
2015
|
||||||||||
|
|
|
($ in thousands)
|
||||||||||||
|
Frequency
|
|
$
|
128,327
|
|
|
92.9
|
%
|
|
$
|
88,761
|
|
|
93.6
|
%
|
|
Severity
|
|
9,785
|
|
|
7.1
|
|
|
6,032
|
|
|
6.4
|
|
||
|
Total
|
|
$
|
138,112
|
|
|
100.0
|
%
|
|
$
|
94,793
|
|
|
100.0
|
%
|
|
|
|
Three months ended March 31
|
||||||||||||
|
|
|
2016
|
|
2015
|
||||||||||
|
|
|
($ in thousands)
|
||||||||||||
|
Frequency
|
|
$
|
87,558
|
|
|
96.6
|
%
|
|
$
|
61,597
|
|
|
97.5
|
%
|
|
Severity
|
|
3,110
|
|
|
3.4
|
|
|
1,610
|
|
|
2.5
|
|
||
|
Total
|
|
$
|
90,668
|
|
|
100.0
|
%
|
|
$
|
63,207
|
|
|
100.0
|
%
|
|
|
|
Three months ended March 31
|
||||
|
|
|
2016
|
|
2015
|
||
|
Frequency
|
|
68.2
|
%
|
|
69.4
|
%
|
|
Severity
|
|
31.8
|
%
|
|
26.7
|
%
|
|
Total
|
|
65.6
|
%
|
|
66.7
|
%
|
|
|
Three months ended March 31
|
||||||||||||||||||||||
|
|
|
|
2016
|
|
|
|
|
|
2015
|
|
|
||||||||||||
|
|
Gross
|
|
Ceded
|
|
Net
|
|
Gross
|
|
Ceded
|
|
Net
|
||||||||||||
|
|
($ in thousands)
|
||||||||||||||||||||||
|
Losses paid (recovered)
|
$
|
54,883
|
|
|
$
|
(217
|
)
|
|
$
|
54,666
|
|
|
$
|
65,264
|
|
|
$
|
(9,113
|
)
|
|
$
|
56,151
|
|
|
Change in loss and loss adjustment expense reserves
|
36,182
|
|
|
(180
|
)
|
|
36,002
|
|
|
(1,812
|
)
|
|
8,868
|
|
|
7,056
|
|
||||||
|
Total
|
$
|
91,065
|
|
|
$
|
(397
|
)
|
|
$
|
90,668
|
|
|
$
|
63,452
|
|
|
$
|
(245
|
)
|
|
$
|
63,207
|
|
|
|
|
Three months ended March 31
|
||||||||||||
|
|
|
2016
|
|
2015
|
||||||||||
|
|
|
($ in thousands)
|
||||||||||||
|
Frequency
|
|
$
|
36,578
|
|
|
93.9
|
%
|
|
$
|
25,698
|
|
|
95.7
|
%
|
|
Severity
|
|
2,385
|
|
|
6.1
|
|
|
1,143
|
|
|
4.3
|
|
||
|
Total
|
|
$
|
38,963
|
|
|
100.0
|
%
|
|
$
|
26,841
|
|
|
100.0
|
%
|
|
|
|
Three months ended March 31
|
||||
|
|
|
2016
|
|
2015
|
||
|
Frequency
|
|
28.5
|
%
|
|
29.0
|
%
|
|
Severity
|
|
24.4
|
%
|
|
18.9
|
%
|
|
Total
|
|
28.2
|
%
|
|
28.3
|
%
|
|
|
|
Three months ended March 31
|
||||||
|
|
|
2016
|
|
2015
|
||||
|
|
|
($ in thousands)
|
||||||
|
Underwriting expenses
|
|
$
|
4,823
|
|
|
$
|
3,938
|
|
|
Corporate expenses
|
|
2,176
|
|
|
2,222
|
|
||
|
General and administrative expenses
|
|
$
|
6,999
|
|
|
$
|
6,160
|
|
|
|
|
Three months ended March 31
|
||||||
|
|
|
2016
|
|
2015
|
||||
|
|
|
($ in thousands)
|
||||||
|
Realized gains (losses)
|
|
$
|
(38,611
|
)
|
|
$
|
25,010
|
|
|
Change in unrealized gains and losses
|
|
78,700
|
|
|
(31,613
|
)
|
||
|
Investment related foreign exchange gains (losses)
|
|
(4,112
|
)
|
|
(7,973
|
)
|
||
|
Interest and dividend income, net of withholding taxes
|
|
4,956
|
|
|
3,426
|
|
||
|
Interest, dividend and other expenses
|
|
(5,262
|
)
|
|
(8,476
|
)
|
||
|
Investment advisor compensation
|
|
(7,236
|
)
|
|
(5,203
|
)
|
||
|
Net investment income (loss)
|
|
$
|
28,435
|
|
|
$
|
(24,829
|
)
|
|
|
|
Three months ended March 31
|
||||
|
|
|
2016
|
|
2015
|
||
|
Long portfolio gains (losses)
|
|
2.6
|
%
|
|
3.9
|
%
|
|
Short portfolio gains (losses)
|
|
0.1
|
|
|
(4.4
|
)
|
|
Macro gains (losses)
|
|
0.5
|
|
|
(0.9
|
)
|
|
Other income and expenses
|
|
(0.4
|
)
|
|
(0.4
|
)
|
|
Gross investment return
|
|
2.8
|
%
|
|
(1.8
|
)%
|
|
Net investment return
|
|
2.5
|
%
|
|
(1.8
|
)%
|
|
|
Three months ended March 31
|
|
Three months ended March 31
|
||||||||||||||
|
|
|
|
2016
|
|
|
|
|
|
2015
|
|
|
||||||
|
|
Frequency
|
|
Severity
|
|
Total
|
|
Frequency
|
|
Severity
|
|
Total
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Loss ratio
|
68.2
|
%
|
|
31.8
|
%
|
|
65.6
|
%
|
|
69.4
|
%
|
|
26.7
|
%
|
|
66.7
|
%
|
|
Acquisition cost ratio
|
28.5
|
|
|
24.4
|
|
|
28.2
|
|
|
29.0
|
|
|
18.9
|
|
|
28.3
|
|
|
Composite ratio
|
96.7
|
%
|
|
56.2
|
%
|
|
93.8
|
%
|
|
98.4
|
%
|
|
45.6
|
%
|
|
95.0
|
%
|
|
Underwriting expense ratio
|
|
|
|
|
3.5
|
|
|
|
|
|
|
4.8
|
|
||||
|
Combined ratio
|
|
|
|
|
97.3
|
%
|
|
|
|
|
|
99.8
|
%
|
||||
|
•
|
Fluctuations in the share price due to an overall positive investment market;
|
|
•
|
Sudden unexpected changes in the underlying business model of the issuer;
|
|
•
|
Changes in laws and regulations relating to short sales;
|
|
•
|
Press releases and earnings guidance issued by the issuer;
|
|
•
|
A merger or acquisition of the issuer at a price in excess of the current share price;
|
|
•
|
The shares of the issuer becoming difficult to borrow; or
|
|
•
|
A short squeeze.
|
|
|
March 31, 2016
|
|
December 31, 2015
|
||||||||||||||||||||
|
|
Case
Reserves |
|
IBNR
|
|
Total
|
|
Case
Reserves |
|
IBNR
|
|
Total
|
||||||||||||
|
|
($ in thousands)
|
||||||||||||||||||||||
|
Frequency
|
$
|
102,238
|
|
|
$
|
204,750
|
|
|
$
|
306,988
|
|
|
$
|
103,347
|
|
|
$
|
165,740
|
|
|
$
|
269,087
|
|
|
Severity
|
3,390
|
|
|
30,754
|
|
|
34,144
|
|
|
8,188
|
|
|
28,722
|
|
|
36,910
|
|
||||||
|
Total
|
$
|
105,628
|
|
|
$
|
235,504
|
|
|
$
|
341,132
|
|
|
$
|
111,535
|
|
|
$
|
194,462
|
|
|
$
|
305,997
|
|
|
|
|
April 1, 2016
|
||||||
|
Zone
|
|
Maximum Single Event Loss
|
|
Maximum Aggregate Loss
|
||||
|
|
|
($ in thousands)
|
||||||
|
United States, Canada and the Caribbean
|
|
$
|
166,697
|
|
|
$
|
236,707
|
|
|
Europe
|
|
111,665
|
|
|
139,195
|
|
||
|
Japan
|
|
111,665
|
|
|
139,195
|
|
||
|
Rest of the world
|
|
111,665
|
|
|
139,195
|
|
||
|
Maximum Aggregate
|
|
166,697
|
|
|
236,707
|
|
||
|
|
|
April 1, 2016
|
||||||
|
|
|
1-in-250 year return period
|
||||||
|
Zone
|
|
Single Event Loss
|
|
Aggregate Loss
|
||||
|
|
|
($ in thousands)
|
||||||
|
United States, Canada and the Caribbean
|
|
$
|
103,240
|
|
|
$
|
126,536
|
|
|
Europe
|
|
44,339
|
|
|
58,605
|
|
||
|
Japan
|
|
27,915
|
|
|
36,612
|
|
||
|
Rest of the world
|
|
28,215
|
|
|
43,172
|
|
||
|
Maximum
|
|
103,240
|
|
|
129,345
|
|
||
|
|
Less than
1 year |
|
1-3 years
|
|
3-5 years
|
|
More than
5 years |
|
Total
|
||||||||||
|
|
($ in thousands)
|
||||||||||||||||||
|
Operating lease obligations
(1)
|
$
|
552
|
|
|
$
|
754
|
|
|
$
|
172
|
|
|
$
|
11
|
|
|
$
|
1,489
|
|
|
Private equity and limited partnerships
(2)
|
5,282
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,282
|
|
|||||
|
Loss and loss adjustment expense reserves
(3)
|
154,541
|
|
|
95,612
|
|
|
46,062
|
|
|
44,917
|
|
|
341,132
|
|
|||||
|
|
$
|
160,375
|
|
|
$
|
96,366
|
|
|
$
|
46,234
|
|
|
$
|
44,928
|
|
|
$
|
347,903
|
|
|
•
|
|
equity price risk;
|
|
|
|
|
|
•
|
|
commodity price risk;
|
|
|
|
|
|
•
|
|
foreign currency risk;
|
|
|
|
|
|
•
|
|
interest rate risk;
|
|
|
|
|
|
•
|
|
credit risk; and
|
|
|
|
|
|
•
|
|
political risk.
|
|
|
10% increase in commodity prices
|
|
10% decrease in commodity prices
|
||||||||||
|
Commodity
|
Change in
fair value |
|
Change in fair value as % of investment portfolio
|
|
Change in
fair value |
|
Change in fair value as % of investment portfolio
|
||||||
|
|
($ in thousands)
|
|
|
|
($ in thousands)
|
|
|
||||||
|
Gold
|
$
|
14,689
|
|
|
1.3
|
%
|
|
$
|
(14,689
|
)
|
|
(1.3
|
)%
|
|
Natural Gas
|
5,916
|
|
|
0.5
|
|
|
(5,916
|
)
|
|
(0.5
|
)
|
||
|
Total
|
$
|
20,605
|
|
|
1.8
|
%
|
|
$
|
(20,605
|
)
|
|
(1.8
|
)%
|
|
|
|
|
|
|
|
|
|
||||||
|
|
10% increase in U.S. dollar
|
|
10% decrease in U.S. dollar
|
||||||||||
|
Foreign Currency
|
Change in
fair value |
|
Change in fair value as % of investment portfolio
|
|
Change in
fair value |
|
Change in fair value as % of investment portfolio
|
||||||
|
|
($ in thousands)
|
||||||||||||
|
Argentine Peso
|
$
|
(1,986
|
)
|
|
(0.2
|
)%
|
|
$
|
1,986
|
|
|
0.2
|
%
|
|
British Pound
|
(1,639
|
)
|
|
(0.1
|
)
|
|
1,639
|
|
|
0.1
|
|
||
|
Chinese Yuan
|
10,922
|
|
|
1.0
|
|
|
(2,224
|
)
|
|
(0.2
|
)
|
||
|
Japanese Yen
|
765
|
|
|
0.1
|
|
|
(497
|
)
|
|
—
|
|
||
|
Other
|
696
|
|
|
0.1
|
|
|
(696
|
)
|
|
(0.1
|
)
|
||
|
Total
|
$
|
8,758
|
|
|
0.9
|
%
|
|
$
|
208
|
|
|
—
|
%
|
|
|
100 basis point increase
in interest rates |
|
100 basis point decrease
in interest rates |
||||||||||
|
|
Change in
fair value |
|
Change in fair value as % of investment portfolio
|
|
Change in
fair value |
|
Change in fair value as % of investment portfolio
|
||||||
|
|
($ in thousands)
|
||||||||||||
|
Debt instruments
|
$
|
3,610
|
|
|
0.3
|
%
|
|
$
|
(5,016
|
)
|
|
(0.4
|
)%
|
|
Net exposure to interest rate risk
|
$
|
3,610
|
|
|
0.3
|
%
|
|
$
|
(5,016
|
)
|
|
(0.4
|
)%
|
|
12.1
|
Ratio of Earnings to Fixed Charges and Preferred Share Dividends
|
|
31.1
|
Certification of the Chief Executive Officer filed hereunder pursuant to Section 302 of the Sarbanes Oxley Act of 2002
|
|
31.2
|
Certification of the Chief Financial Officer filed hereunder pursuant to Section 302 of the Sarbanes Oxley Act of 2002
|
|
32.1
|
Certification of the Chief Executive Officer filed hereunder pursuant to Section 906 of the Sarbanes Oxley Act of 2002 (*)
|
|
32.2
|
Certification of the Chief Financial Officer filed hereunder pursuant to Section 906 of the Sarbanes Oxley Act of 2002 (*)
|
|
101
|
The following materials from the Company’s Quarterly Report on Form 10-Q for the three months ended March 31, 2016 formatted in XBRL (eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets; (ii) the Condensed Consolidated Statements of Income; (iii) the Condensed Consolidated Statements of Shareholders’ Equity; (iv) the Condensed Consolidated Statements of Cash Flows; and (v) the Notes to Condensed Consolidated Financial Statements.
|
|
*
|
Furnished herewith.
|
|
|
GREENLIGHT CAPITAL RE, LTD.
|
|
|
|
|
(Registrant)
|
|
|
|
|
By:
|
/s/ BARTON HEDGES
|
|
|
|
|
Barton Hedges
Director & Chief Executive Officer (principal executive officer) |
|
|
|
|
May 2, 2016
|
|
|
|
|
|
|
|
|
By:
|
/s/ TIM COURTIS
|
|
|
|
|
Tim Courtis
Chief Financial Officer (principal financial and accounting officer) |
|
|
|
|
May 2, 2016
|
|
|
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|